美敦力Omniasecure™除颤导线获FDA批准用于传导系统起搏,创行业先河

美股速递
Mar 23

美敦力公司旗下Omniasecure™除颤导线成功获得美国食品药品监督管理局(FDA)批准,可用于传导系统起搏治疗。这一突破使其成为同类产品中首个获此适应症批准的除颤导线。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10